Kenneth Keller

Kenneth Keller

Direktör/Styrelseledamot på AMBIT BIOSCIENCES CORP
63 år
Health Technology
Consumer Services

Profil

Kenneth Joseph Keller is currently Chairman, President & Chief Executive Officer at Daiichi Sankyo, Inc. since 2014.
Mr. Keller is also Director at Ambit Biosciences Corp.
since 2014.
Mr. Keller serves as Director & Head-Oncology Business Unit at Daiichi Sankyo Co., Ltd. starting in 2021.
Formerly, Mr. Keller was President & Chief Executive Officer at American Regent, Inc. from 2016 to 2021.
Mr. Keller was Chief Operating Officer & Executive Vice President at Spectrum Pharmaceuticals, Inc. from 2012 to 2014.
Mr. Keller earned an MBA from Loyola Marymount University and completed undergraduate studies at St. John's University.

Aktiva positioner av Kenneth Keller

FöretagPositionStart
AMBIT BIOSCIENCES CORP Direktör/Styrelseledamot 2014-11-10
DAIICHI SANKYO COMPANY, LIMITED Direktör/Styrelseledamot 2025-06-01
Verkställande Direktör 2014-03-01

Tidigare kända positioner av Kenneth Keller

FöretagPositionSlut
Verkställande Direktör 2021-04-01
SPECTRUM PHARMACEUTICALS, INC. Verksamhetschef 2014-04-17
Se detaljerna i Kenneth Kellers erfarenhet

Kenneth Kellers utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

60

Första gradens relationer

7

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Kenneth Keller